Metformin Safety Update

Metformin Safety Update

December 12, 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has been made aware that outside of the UK very low amounts of an impurity, N-nitrosodimethylamine (NDMA), have been found in some metformin diabetes medicines.

MHRA have advised that patients in the UK should continue to take their metformin medicines as usual. MHRA have added that the risks from not having adequate diabetes treatment far outweigh any possible effects of low levels of NDMA seen in metformin medicines outside the UK. The levels of NDMA seen in the non-UK metformin are very low and appear to be within or even below the range that people would be normally exposed from other sources including food or water.

The European Medicines Agency (EMA) are investigating this situation, click here to see the latest update.



Posted in:


More Latest News >

Wuhan Novel Coronavirus

The Medicines & Healthcare products Regulatory Agency (MHRA) has via its Central Alerting System (CAS) published an alert regarding the...